HomeANR • ASX
Anatara Lifesciences Ltd
add
Market news
.INX
0.83%
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(AUD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 261.63K | 91.85% |
Operating expense | 387.96K | 25.58% |
Net income | -580.54K | -70.95% |
Net profit margin | -221.89 | 10.89% |
Earnings per share | — | — |
EBITDA | -582.54K | -71.06% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(AUD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.10M | 1.58% |
Total assets | 1.76M | 23.06% |
Total liabilities | 403.91K | 148.40% |
Total equity | 1.36M | — |
Shares outstanding | 213.38M | — |
Price to book | 0.80 | — |
Return on assets | -82.76% | — |
Return on capital | -107.40% | — |
Cash Flow
Net Change in Cash
Net change in cash
(AUD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -580.54K | -70.95% |
Cash from operations | -449.75K | -211.20% |
Cash from investing | -25.00K | — |
Cash from financing | 509.56K | 4.80% |
Net change in cash | 34.81K | -89.81% |
Free cash flow | -321.97K | -49.89% |
Previous close
$0.0080
Year range
$0.0060 - $0.073
Market cap
1.19M AUD
Avg Volume
2.11M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
About
Founded
2010
Website